116 related articles for article (PubMed ID: 16943256)
1. Identification of bombesin receptor subtype-specific ligands: effect of N-methyl scanning, truncation, substitution, and evaluation of putative reported selective ligands.
Mantey SA; Gonzalez N; Schumann M; Pradhan TK; Shen L; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2006 Nov; 319(2):980-9. PubMed ID: 16943256
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
[TBL] [Abstract][Full Text] [Related]
3. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
Mantey SA; Coy DH; Entsuah LK; Jensen RT
J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
[TBL] [Abstract][Full Text] [Related]
4. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
[TBL] [Abstract][Full Text] [Related]
6. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
7. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
Uehara H; González N; Sancho V; Mantey SA; Nuche-Berenguer B; Pradhan T; Coy DH; Jensen RT
Peptides; 2011 Aug; 32(8):1685-99. PubMed ID: 21729729
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
Moody TW; Sun LC; Mantey SA; Pradhan T; Mackey LV; Gonzales N; Fuselier JA; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2006 Sep; 318(3):1265-72. PubMed ID: 16766720
[TBL] [Abstract][Full Text] [Related]
10. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
[TBL] [Abstract][Full Text] [Related]
12. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2).
Darker JG; Brough SJ; Heath J; Smart D
J Pept Sci; 2001 Nov; 7(11):598-605. PubMed ID: 11763364
[TBL] [Abstract][Full Text] [Related]
14. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
[TBL] [Abstract][Full Text] [Related]
15. The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3).
Boyle RG; Humphries J; Mitchell T; Showell GA; Apaya R; Iijima H; Shimada H; Arai T; Ueno H; Usui Y; Sakaki T; Wada E; Wada K
J Pept Sci; 2005 Mar; 11(3):136-41. PubMed ID: 15635635
[TBL] [Abstract][Full Text] [Related]
16. Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cells.
Ramos-Álvarez I; Nakamura T; Mantey SA; Moreno P; Nuche-Berenguer B; Jensen RT
Peptides; 2016 Jan; 75():8-17. PubMed ID: 26524625
[TBL] [Abstract][Full Text] [Related]
17. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
Orbuch M; Taylor JE; Coy DH; Mrozinski JE; Mantey SA; Battey JF; Moreau JP; Jensen RT
Mol Pharmacol; 1993 Oct; 44(4):841-50. PubMed ID: 7901752
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
Ryan RR; Katsuno T; Mantey SA; Pradhan TK; Weber HC; Coy DH; Battey JF; Jensen RT
J Pharmacol Exp Ther; 1999 Sep; 290(3):1202-11. PubMed ID: 10454496
[TBL] [Abstract][Full Text] [Related]
20. Appetite-modifying effects of bombesin receptor subtype-3 agonists.
Majumdar ID; Weber HC
Handb Exp Pharmacol; 2012; (209):405-32. PubMed ID: 22249826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
